Clarivate (NYSE:CLVT - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 0.600-0.700 for the period, compared to the consensus estimate of 0.610. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.4 billion.
Clarivate Trading Down 1.2%
Shares of NYSE:CLVT opened at $3.66 on Wednesday. Clarivate has a 52-week low of $3.04 and a 52-week high of $6.72. The stock has a market cap of $2.46 billion, a price-to-earnings ratio of -5.90 and a beta of 1.44. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.90. The business has a 50-day moving average price of $3.99 and a 200-day moving average price of $4.09.
Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.18 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.18. Clarivate had a positive return on equity of 8.65% and a negative net margin of 17.33%.The firm had revenue of $621.40 million during the quarter, compared to analysts' expectations of $587.17 million. During the same period last year, the business posted $0.20 earnings per share. The company's revenue for the quarter was down 4.4% compared to the same quarter last year. Equities analysts predict that Clarivate will post 0.63 EPS for the current year.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on CLVT shares. Jefferies Financial Group initiated coverage on Clarivate in a research note on Friday, July 18th. They issued a "hold" rating and a $4.50 price objective for the company. Weiss Ratings reiterated a "sell (d-)" rating on shares of Clarivate in a research report on Tuesday, October 14th. Finally, Wolfe Research initiated coverage on Clarivate in a research report on Wednesday, September 3rd. They set a "peer perform" rating for the company. Four equities research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Reduce" and a consensus price target of $4.83.
Read Our Latest Stock Report on CLVT
Institutional Trading of Clarivate
A number of institutional investors have recently made changes to their positions in CLVT. Royal Bank of Canada boosted its stake in shares of Clarivate by 96.2% in the first quarter. Royal Bank of Canada now owns 63,630 shares of the company's stock worth $250,000 after acquiring an additional 31,197 shares during the last quarter. AQR Capital Management LLC grew its holdings in Clarivate by 37.0% in the 1st quarter. AQR Capital Management LLC now owns 451,872 shares of the company's stock valued at $1,749,000 after buying an additional 122,099 shares in the last quarter. Millennium Management LLC grew its holdings in Clarivate by 1,420.4% in the 1st quarter. Millennium Management LLC now owns 1,188,978 shares of the company's stock valued at $4,673,000 after buying an additional 1,110,774 shares in the last quarter. Goldman Sachs Group Inc. grew its holdings in Clarivate by 15.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 616,250 shares of the company's stock valued at $2,422,000 after buying an additional 82,768 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Clarivate by 13.1% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,243,683 shares of the company's stock valued at $4,888,000 after buying an additional 144,462 shares in the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.
Clarivate Company Profile
(
Get Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.